Medicine & Health

Researchers at WashU Medicine engineered a yeast probiotic to deliver immunotherapy to the gut where it reduced gastrointestinal tumors in mice, offering a potentially novel strategy to target hard-to-reach gut cancers.

COVID-19 reshaped mobility patterns worldwide, affecting walking, driving and public transit use, finds a new study published in The Lancet Public Health. The research, led by an international team including some Brown School researchers, analyzed data from nearly 300 cities to understand how urban transportation habits adapted during the pandemic.

Brain science researchers at WashU are studying how the brain perceives, processes and remembers everyday events. Their goal is to create an intervention that could improve memory by helping people segment events.

Researchers at WashU have used AI tools to describe three sub-types of Chiari type-1, which will help guide clinicians to make the most effective treatment decisions for their patients.

A small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

Washington University School of Medicine in St. Louis and BJC Health System have launched the joint Center for Health AI. The center will focus on making care more personalized and effective for patients and more efficient and manageable for physicians, nurses and all those striving to ensure patients receive the best care.

Andrew Yoo, a professor of developmental biology at WashU Medicine, has received the 2024 Transformative Research Award, a two-year $1 million grant from the Hereditary Disease Foundation.

Researchers at WashU Medicine have identified a possible way to make brain cancer cells vulnerable to different types of immunotherapy, in hopes of finding new treatments for one of the most deadly cancers.

Researchers at WashU Medicine collaborated with an international team of doctors and scientists to identify the cause of a rare genetic disorder involving intellectual disability and brain malformations.

Sheng Chih (Peter) Jin, an assistant professor of genetics at WashU Medicine, has received a $3.2 million grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) to study the genetic and molecular underpinnings of congenital hydrocephalus.